Su Pin Choo

TL;DR: In conclusion, clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms and the role of beta-catenin in this population is still under investigation.

TL;DR: It is presented three patients with advanced hepatocellular carcinoma with the openended question, “And what other medications are you taking?” and identified a traditional Chinese medicine, Ling Zhi (Ganoderma lucidum), that has, at least in the authors' experience, been associated with a few durable remissions.

TL;DR: These expert statements summarize the latest data and expert opinion on selecting systemic treatment following first-line therapy in patients with unresectable advanced or metastatic HCC and recommend therapies in special circumstances, such as poor liver function, posttransplantation, recent gastrointestinal bleeding, or autoimmune diseases.

TL;DR: In this paper, an expert opinion review examines the key challenges to the clinical adoption of NGS-based diagnostics in Singapore, provides recommendations on impactful initiatives to improve adoption, and also offers practical guidance on specific cancer types in which NGS based diagnostics are appropriate for use in Singapore.

TL;DR: Overexpression/activation of c MET occurs in 20‒48% of HCC, and predicts worse survival, and Capmatinib (INC280) is a potent, selective cMET inhibitor that causes regression of cMET dysr...